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Abstract
Background: Dengue virus pathogenesis is not yet fully understood and the identification of
patients at high risk for developing severe disease forms is still a great challenge in dengue patient
care. During the present study, we evaluated prospectively the potential of cytokines present in
plasma from patients with dengue in stratifying disease severity.
Methods: Seventeen-cytokine multiplex fluorescent microbead immunoassay was used for the
simultaneous detection in 59 dengue patients. GLM models using bimodal or Gaussian family were
determined in order to associate cytokines with clinical manifestations and laboratory diagnosis.
Results: IL-1β, IFN-γ, IL-4, IL-6, IL-13, IL-7 and GM-CSF were significantly increased in patients
with severe clinical manifestations (severe dengue) when compared to mild disease forms (mild
dengue). In contrast, increased MIP-1β levels were observed in patients with mild dengue. MIP-1β
was also associated with CD56+NK cell circulating rates. IL-1β, IL-8, TNF-α and MCP-1 were
associated with marked thrombocytopenia. Increased MCP-1 and GM-CSF levels correlated with
hypotension. Moreover, MIP-1β and IFN-γ were independently associated with both dengue
severity and disease outcome.
Conclusion: Our data demonstrated that the use of a multiple cytokine assay platform was
suitable for identifying distinct cytokine profiles associated with the dengue clinical manifestations
and severity. MIP-β is indicated for the first time as a good prognostic marker in contrast to IFN-
γ that was associated with disease severity.
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Background
During the last decades dengue became the most impor-
tant arthropod-borne emerging viral disease in tropical
countries [1]. It is estimated that about 2.5% notified
cases are classified as dengue haemorrhagic fever (DHF)
and about 2.5–20% of DHF cases are lethal [2-4]. In the
last two decades, Latin America saw a dramatic increase in
frequency and in geographic extension of dengue fever.
Specifically, the situation in Brazil has worsened during
the last decade since the introduction of the Dengue-3
serotype. In the past years Brazil had dengue outbreaks
with at least 1 million cases (2001–2002) and within the
last 18 months 900 thousand cases were reported [5]. In
addition, severe disease forms are occurring with
increased frequency and mortality rates.
Dengue pathogenesis is not completely understood, and
the main determinants of the development of severe
forms are not yet well established. Increase in capillary
permeability associated with endothelial activation and
haemorrhagic phenomena are landmarks of severe clini-
cal manifestations, strongly suggesting an alteration in
immunoregulation [6].
Cytokines are proteins secreted during innate and adap-
tive immunological responses, acting as inflammatory
mediators or modulatory molecules during several haem-
orrhagic fevers [7]. Clinical studies support a key role for
cytokines in the DHF pathogenesis [8-13]. During Dengue
virus infections, cytokines are involved in the disease
onset and homeostatic regulation. Specifically, TNF-α, IL-
1β and IL-6 have been associated with both coagulation
(F1+2 and TATc) and fibrinolysis (t-PA, PAPc, and D-dim-
mer) activation markers [14]. This activation is more strik-
ing in patients with severe clinical manifestations,
although it can be found at lower degrees in patients with
mild disease [15,16].
Despite the fact that cytokine network and their multiple
regulatory pathways are highly complex and not fully elu-
cidated during dengue fever, these molecules seem to rep-
resent interesting markers for patient stratification or
prognosis. An emerging interest has appeared in order to
define biomarkers that may have pathophysiological roles
during disease and that may be used as future therapeutic
targets. New technologies have been developed in order to
detect multiple biomarkers within a single and small
blood sample. Such approaches may lead to the develop-
ment of specific marker panels for dengue fever. Accord-
ingly, cytokine patterns have been indicated as serum
biomarkers during infectious diseases such as Hepatitis C
[17], ARDS [18] and sepsis [19].
In this study, we prospectively evaluated the potential use
of plasma cytokine concentrations for severity stratifica-
tion of patients with dengue, using a 17 cytokine-multi-
plex assay. Among tested cytokines, we were able to
recognize ten significantly altered circulating factors and
to characterise cytokine patterns related to determined
clinical manifestations and disease severity.
Methods
Study population
The Ethics Committee of the Oswaldo Cruz Foundation
approved this study protocol and written informed con-
sent was obtained from all patients or their guardians
prior to blood collection.
We included prospectively 59 dengue-infected patients
(33 females, 26 males, age range 15–73 years) assisted at
three Health Centres in Niterói, Rio de Janeiro State
(Posto de Saúde de Itaipú, Centro Previdenciário de Nit-
erói and Hospital das Clínicas de Niterói). All patients
presented clinical diagnosis of dengue infection according
to WHO criteria [3]. Among dengue patients, 39 cases
were hospitalised due to severity.
A detailed history and physical examination was per-
formed to detect hemorrhagic manifestations (positive
tourniquet test for capillary fragility, skin haemorrhages,
epistaxis, gingival, gastrointestinal, or urinary tract haem-
orrhage), signs of plasma leakage (pleural or pericardial
effusion, ascites), signs of circulatory failure (cold extrem-
ities, cyanosis, hypotension, tachycardia, shock), and
hepatomegaly.
Case definition
In addition to the suggestive clinical diagnosis, all patients
had the Dengue virus infection confirmed either by anti-
dengue enzyme-linked immunoabsorbent assay (ELISA)-
IgM, serotype specific reverse transcription-polymerase
chain reaction (RT-PCR) or by virus isolation [20-22].
Dengue immune response was considered as primary or
secondary by IgG ELISA according to previously estab-
lished criteria [23].
As previously reported [24-26], we also were often unable
to characterize the severe disease forms based on WHO
criteria [3]. In Nicaragua, Harris et al. [24,27] described
four key severe clinical manifestations associated with
dengue – shock, plasma leakage, marked thrombocytope-
nia or internal haemorrhage – that do not fit DHF/DSS
classification as single parameters. According to these cri-
teria, we considered:
￿ Severe dengue – Dengue confirmed cases plus severe
thrombocytopenia (<50,000 platelets/mm3) and/or
hypotension (postural hypotension with decrease in
systolic arterial pressure in 20 mm Hg in supine position
or systolic arterial pressure < 90 mm Hg) and/or plasmaBMC Infectious Diseases 2008, 8:86 http://www.biomedcentral.com/1471-2334/8/86
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leakage (either haemoconcentration fluctuation of packed
cell volume ≥ 20% during illness course and recovery or
clinical signs of plasma leakage, such as pleural effusion)
and/or severe haemorrhagic manifestations.
￿ Mild dengue – Dengue confirmed cases in absence of
severe thrombocytopenia, hypotension, plasma leakage
signs or haemorrhagic manifestations.
Blood samples and cytokine detection by multiplex 
microbead immunoassay
Blood samples were collected from a peripheral vein and
kept on ice. Plasma was collected by centrifugation at 800
g for 15 min at 4°C, aliquoted, and stored at -70°C until
the analysis day. A multiplex biometric immunoassay,
containing fluorescent dyed microspheres conjugated
with a monoclonal antibody specific for a target protein,
was used for cytokine measurement according to the man-
ufacturer's instructions (Bio-Plex Human Cytokine Assay;
Bio-Rad Inc., Hercules, CA, USA). Cytokines measured
were: IL-1β, IL-2, IL-4, IL-5, IL-6, IL-7, CXCL8 (IL-8), IL-
10, IL-12 (p70), IL-13, IL-17, granulocyte colony stimulat-
ing factor (G-CSF), granulocyte-monocyte colony stimu-
lating factor (GM-CSF), monocyte chemoattractive
protein (MCP-1/CCL2), macrophage inflammatory pro-
tein (MIP-1β/CCL4), and TNF-α. Briefly, 20 μl plasma
samples were diluted 1:4 and incubated with antibody-
coupled beads. Complexes were washed, then incubated
with biotinylated detection antibody and, finally, with
streptavidin-phycoerythrin prior to assessing cytokine
concentration titres. Concentrated human recombinant
cytokine was provided by the vendor (Bio-Rad Laborato-
ries). A range of 1.95–32,000 pg/ml recombinant
cytokines was used to establish standard curves and to
maximize the sensitivity and the assay dynamic range.
Cytokine levels were determined using a multiplex array
reader from Luminex™ Instrumentation System (Bio-Plex
Workstation from Bio-Rad Laboratories). The analyte con-
centration was calculated using software provided by the
manufacturer (Bio-Plex Manager Software).
Extracellular staining for flow cytometry analysis
Liquid nitrogen cryopreserved peripheral blood mononu-
clear leukocytes were isolated by Histopaque-1077
(Sigma Chemical Co., Saint Louis, MO, USA) from 35 out
of 59 dengue patients. Cells were stained for CD56 surface
marker using anti-CD56-Cy5 (IgG1, clone B159) from
Pharmingen (San Diego, CA, USA) and positive cells were
detected by flow cytometry as described before [22] using
FACScalibur (Becton-Dickinson). Events (10,000–
20,000) were acquired and analyses were carried out with
FlowJo (TreeStar, version 4.3) software.
Statistical analyses
The nonparametric Mann-Whitney U test was used to
evaluate differences between cytokine ratios from severe
and mild dengue patients.
GLM models were used to evaluate factors independently
associated with quantitative variables. Analysis of factors
independently associated with dengue severity and other
clinical manifestations was performed with GLM with
logistic regression or Gaussian family. Results from the
logistic regressions are given as odds ratio (OR). The con-
fidence interval (CI) was established at 95%. Alterna-
tively, for a GLM Gaussian family t values were recorded.
A probability value of P<0.05 was considered to be signif-
icant. The statistical programs R [28] and Prism 4 (Graph-
Pad Software, San Diego, CA, USA) were employed.
The Fisher's exact test was applied to determine the signif-
icance of positive samples from patients when comparing
different virus serotypes or sequential infections. Correla-
tion between platelet counts and cytokine production in
blood samples was estimated by Spearman's correlation.
Results
Clinical characterisation of dengue disease in adult 
Brazilian patients
From the 59 patients included, 39 were classified as severe
dengue and 20 as mild dengue. Detailed demographic,
clinical, and laboratorial data from dengue patients are
summarized in Table 1. Blood collection was performed
between 3 and 10 days after disease onset. In order to
avoid effects due to differences in the blood collection
time, we compared mild and severe dengue patient
groups using Mann-Whitney U Test, which showed no dif-
ferences in the disease onset time at the moment of sam-
ple collection [see Additional file 1]. The original data
used to perform this analysis is shown at Figure 1.
Patients with mild and severe dengue were investigated
for prior incidence of infection, detected by serologic
immune response (IgG antibodies for DENV). Patients
with severe dengue (42%; 14 out 33) were more likely to
be experiencing a secondary Dengue virus infection than
patients with mild dengue (28%; 6 out 20), although no
statistical significance was found in Fisher's exact test (P =
0.3989). Among 22 patients with DENV-1, 5 were classi-
fied as secondary infection, whereas among 35 patients
with DENV-3, 12 were classified as secondary infection (P
= 0.3912).
Circulating cytokines are elevated in dengue patients 
during early febrile phase increasing their levels during 
defervescence
Dengue fever is characterised by a high fever phase and an
abrupt drop in body temperature that has been calledBMC Infectious Diseases 2008, 8:86 http://www.biomedcentral.com/1471-2334/8/86
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defervescence phase. Characteristically the disease out-
come is defined during this phase, when patients can
either recover rapidly or progress to a severe life-threaten-
ing stage. Cytokines and immunoactivation markers such
as IFN-γ, IL-2, soluble CD8 and receptors for TNF-α
[12,29] are associated with the defervescence phase and
with disease severity. IFN-α levels are higher in DHF than
in DF during defervescence [30].
During the febrile phase significant increase in cytokine
circulating levels was detected including IL-4, IL-6, IL-10,
MCP-1 and MIP-1β levels, which were maintained also
elevated in defervescence (data not shown, analysed by
non parametric Kruskal-Wallis test and Dunn's Multiple
Comparison Test when compared with controls, P <
0.05); no significantly altered febrile levels were found
when compared to defervescence. During the febrile
Cytokine levels in plasma from patients with mild and severe dengue Figure 1
Cytokine levels in plasma from patients with mild and severe dengue. Box-and-whiskers graph. The box extends 
from the 25th to the 75th percentile and the line at the middle is the median. The error bars, or whiskers extend down to the 
lowest value and up to the highest. Factors were sorted according to their functional groups. Mann-Whitney U test was used 
to evaluate differences between cytokine concentration from severe and mild dengue patients. * P < 0.05, ** P < 0.01 and ** P 
< 0.001.
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phase IL-7 was significantly higher than in defervescence.
IL-1β, IL-13, IFN-γ were significantly increased during
defervescence as compared to control samples. Significant
levels of IL-5, IL-12, and IL-17 were not detected during
dengue disease in our patients. IL-2 was detected both in
healthy individuals and in dengue patients but no differ-
ence between these two groups was detected [see Addi-
tional file 2].
Plasma cytokine levels are changed in patients with severe 
dengue and other clinical manifestations
We studied the cytokine profile from Brazilian patients in
order to compare severe and mild dengue cases during the
acute phase of the disease. Figure 1 shows data from
patients with regard to their plasma cytokine contents,
which were sorted in four groups according to their
reported function. We observed that cytokine concentra-
tions of IL-1β, IFN-γ, IL-4, IL-6, IL-7, IL-13 and GM-CSF
were significantly increased during severe dengue as com-
pared to mild dengue, while MIP-1β levels are higher in
mild dengue.
MIP-1β and IFN-γ were independent variables associated
disease outcome as determined by a logistic regression
model (Table 2 and Figure 2). While MIP-1β was
increased during mild dengue with odds ratio (OR) of
0.181 and confidence interval (CI) 0.045–0.72, IFN-γ was
associated with severity with OR of 1.138 (CI, 1.0541–
1.245).
To assess relationships between cytokine levels and sev-
eral clinical manifestations, the patient cohort with severe
dengue was divided into distinct subgroups: those with
hypotension, thrombocytopenia (≤50.000 counts/mm3)
and/or haemorrhagic manifestations. A logistic regression
model was used for binomial response subgroups and
GLM models using Gaussian family were employed for
subgroups with continuous response in order to deter-
mine cytokine profiles.
IL-1β was associated with marked thrombocytopenia with
OR = 1.058 (CI, 1.012–1.106) in dengue patients. TNF-α
was inversely related to thrombocytopenia with OR =
0.978 (CI, 0.962–0.995) (Table 2, Figure 2). Considering
platelet counts as a continuous variable for statistical anal-
ysis with a Gaussian family, it was possible to determine
that IL-8 (P = 0.0434) and MCP-1 (P = 0.0146) levels are
inversely related to their counts, displaying therefore an
association with thrombocytopenia, while MIP-1β (P =
0.0114) confirms its association with higher counts – nor-
mal or tending to normal (Table 3).
GM-CSF (OR = 1.004; CI, 1.001–1.007) was related with
hypotension, whereas IL-1β had a negative predictive
Table 1: Demographic information about the study population with dengue fever.
Characteristics Mild1 Severe Fisher's exact test
Age (median years, 25–75%) 2 39, 28–48 37, 23–53
Sex (M:F) (Patient Number) 7:13 26:13
DENV-1: DENV-3 (Patient Number) 20:0 8:31 p < 0.0001
%3 N4 % N
Fever 30 20 8 37
Haemorrhagic manifestations5 35 20 41 37
Petechia 21 19 49 37
Abdominal Pain 19 16 33 36
Thrombocytopenia (<100.000 counts/mm3) 63 19 72 39
Thrombocytopenia (<50.000 counts/mm3) 0 19 46 39
Hipotension6 0 20 67 39
Hemoconcentration7 33 15 10 39
Secondary Infection 26 19 42 33 P = 0.37
1 See Methods for mild and severe dengue definition.
2 Study population with 59 patients with 3–10 days of disease onset.
3 Percentage of positive patients for the measured parameter within the group.
4 Number of patients used for the measured parameter within the group.
5 Epistaxis, gengivorrhagia, positive tourniquet test, metrorrhagia, bleeding after coughing.
6Postural hypotension with decrease in systolic arterial pressure in 20 mmHg in supine position or systolic arterial pressure < 90 mmHg.
7 Elevated hematocrit for matched age and sex (women>41%; men >45%) or fluctuation of packed cell volume ≥ 20% during course of illness and 
recovery.BMC Infectious Diseases 2008, 8:86 http://www.biomedcentral.com/1471-2334/8/86
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value (OR = 0.928; CI, 0862–0.999) and MIP-1β had a
tendency for a good prognostic (OR = 0.996; CI, 0.992–
1.000) as shown in Table 2 and Figure 2.
Natural Killer (NK) cells have been earlier related to mild
cases of dengue [22]. Forty-eight PBMC samples from
thirty-five patients had their CD56+ rates determined by
flow cytometry and a good correlation was observed with
Cytokines detected in plasma as independent factors in predicting severity Figure 2
Cytokines detected in plasma as independent factors in predicting severity. Normal GLM model originated from 
logistic regression analysis using binomial family odds ratios (OD) and 95% confidence intervals (CI). Fifty-nine patients with 
dengue were grouped according with their clinical manifestations: Severe (N = 39), hypotension (N = 24) or thrombocytopenia 
(N = 18). Details on Table 2.
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Table 2: Logistic models with logit links for different clinical manifestations and laboratorial assays during dengue fever based on 
cytokine production.
Severity1 Yes = 39, No = 20 3 Coefficient Error P value (significance)4 OR2 (CI 95% range)
Intercept 10.855 4.150 0.0089** -
Log (MIP-1β +1e-4) - 1.712 0.705 0.0153* 0.181(0.045–0.72)
Log (IFN-γ +1e-4) 0.130 0.046 0.0046** 1.138 (1.041–1.245)
Platelet counts 50.000/mm3 Yes = 18 No = 40 Coefficient Error P value (significance) OR (CI 95% range)
Intercept 0.940 0.943 0.3187 -
MIP-1β -0.010 0.023 0.0057** 0.990 (0.983–0.997)
IL-1β 0.056 0.023 0.0123* 1.058  (1.012–1.106)
TNF-α -0.022 0.008 0.0100* 0.978(0.962–0.995)
MCP-1 0.002 0.001 0.0437* 1.002 (1.0001–1.0036)
Hypotension Yes = 24 No = 35 Coefficient Error P value (significance) OR (CI 95% range)
Intercept 0.357 0.742 0.6302 -
IL-1β 0.075 0.038 0.0454* 0.928  (0.862–0.999)
IL-12 0.005 0.012 0.6516 1.006 (0.982–1.030)
IL-13 -0.013 0.014 0.3519 0.987 (0.960–1.015)
MIP-1β -0.004 0.002 0.0807 0.996  (0.992–1.000)
MCP-1 0.001 0.0007 0.2065 1.001 (0.9995–1.002)
GM-CSF 0.0043 0.0017 0.0214* 1.004 (1.001–1.007)
1Models were chosen according to their best Akaike information criterion (AIC). In this model we used MIP-1β and IFN-γ log values in order to 
obtain a small AIC.
2OD, odds ratio; CI, confidence interval.
3Number of patients.
4 * P < 0.05, ** P < 0.01 and *** P < 0.001.BMC Infectious Diseases 2008, 8:86 http://www.biomedcentral.com/1471-2334/8/86
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their respective MIP-1β plasmatic levels (r = 0.4668; P =
0.0008).
Considering that different cytokines act in the immuno-
logical network as stimulating/up regulating factors and
also in a feedback loop as down regulators, the cytokine
balance might play a role in the immune response out-
come. Therefore we calculated MIP-1β/IFN-γ ratios for
every patient and compared those from mild dengue with
those from severe dengue. Ratio averages ± SEM were
respectively 3032 ± 514 and 864 ± 240 (P = 0.0003; Mann
Whitney U test), confirming our earlier data that these
cytokines are acting as opposing factors. The different
models built here using clinical manifestations as inde-
pendent variables each exhibit specific cytokine profiles.
Discussion
The cytokine profile identified in patients with dengue
may represent a valuable tool for the characterisation of
immunological response patterns and may assist the iden-
tification of patient groups at risk for developing severe
disease. In the present study, the use of a multiplex analy-
sis for cytokine plasma detection in patients with dengue
could identify cytokine profiles associated with the dis-
ease severity.
Early identification and management of severe dengue
disease are essential to prevent death. It has been increas-
ingly recognized that the inflammatory response and
deregulated cytokine production play key roles in the
development of severe clinical manifestations [31]. How-
ever, cytokine profiles associated with dengue evolution
and prognosis are not well established. New technologies
for cytokine quantification were developed including the
multiplex immunofluorescent bead array analysis system,
allowing multiple biomarkers to be tested simultaneously
in a small volume from one single plasma aliquot.
Recently, this methodology has been used for cytokine
profile evaluation during several infectious diseases
including viral infections [17,32,33] and sepsis [19],
among others.
We were able to identify models for cytokine circulation
during dengue acute phase that may vary with clinical
manifestations. MIP-1β was for the first time associated
with a good prognostic and was identified in the different
disease models presented here. MIP-1β has been earlier
detected after Dengue virus cell stimuli in vitro [34,35] but
preliminary studies in vivo did not report their role in
severity. In accordance with a protective role for MIP-1β,
changes in MIP-1β levels were significantly correlated
with decreases in viral titre after Hepatitis C treatment
[17]. In addition, MIP-1β was up regulated in acute infec-
tion in chimpanzees only when viral clearance took place,
but not in those animals which failed to eradicate the
virus [36].
MIP-1β is produced by human monocytes and dendritic
cells upon different stimuli [37] as well as by activated NK
cells [38] and lymphocytes [39,40]. Activated NK cells
release granzyme A, which displays cytolytic functions
and MIP-1β is chemoattractant for NK cells, recruiting
them to inflammatory sites. NK cells have been associated
with mild dengue [22]. Here a good correlation between
MIP-1β plasma levels and NK cells was observed, reinforc-
ing the relevance of these pathways and strongly suggest-
Table 3: Normal GLM models using Gaussian family for different clinical manifestations and laboratorial assays during dengue fever 
based on cytokine production.
MODELS1 Coefficient Standard Error t value P value (>| t|) (significance)
Platelet counts:
(N = 59)
Intercept 81.42 18.9963 4.286 8.7e-05 ***2
IL-1β -0.180 0.1803 -0.998 0.3233
IL-8 -0.194 0.094 -2.075 0.0434 *
IL-13 0.173 0.081 2.145 0.0371 *
MIP-1β 0.130 0.049 2.630 0.0114 *
MCP-1 -0.033 0.013 -2.534 0.0146 *
Hematocrit:
(N = 59)
Intercept 38.850 0.867 44.813 <2e-16 ***
Sex 4.850 1.043 4.649 2.55e-05 ***
IL-1β 0.026 0.012 2.105 0.0405 *
IL-6 -0.002 0.0007 -3.074 0.0035 **
IL-12 0.011 0.004 2.492 0.0162 *
1. Models were chosen according to their best Akaike information criterion (AIC).
2. * P < 0.05, ** P < 0.01 and *** P < 0.001.BMC Infectious Diseases 2008, 8:86 http://www.biomedcentral.com/1471-2334/8/86
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ing their role in dengue protective mechanisms. An early
and efficient virus clearance by direct or indirect NK func-
tions is likely controlling virus replication, restricting
intense immunological activation and the dengue immu-
nopathology and therefore favouring a mild dengue dis-
ease.
In previous studies, TNF-α has been reported to be associ-
ated with severity, mainly during DHF in Brazilian
patients [11,13,41]. In the present study, however, this
cytokine was not strongly associated with severity. Indeed,
other authors also found inconsistency or no difference in
TNF-α levels in severe vs. mild disease forms [10,42]. We
may hypothesize that differences in Dengue virus sero-
types or in host immune response such as different TNF-α
genetic polymorphisms may explain the disease outcome.
In our study from 2001 (Braga et al., 2001), patients were
Dengue-2 infected, while in the present study, patients
were Dengue-1 and -3 infected. A recent report [43]
describes non-significant TNF-α serum levels in adult
patients and suggests that the discrepancy may have been
caused by a transient TNF-α peak which was not detected
at a later time point.
In the present study we observed an association of IFN-γ
with disease severity. Indeed, increased IFN-γ concentra-
tions have been detected in dengue patients in a variety of
studies [29,44-47]. DHF induced by Dengue-3 was associ-
ated with higher viremia early in illness and earlier peak
plasma IFN-γ levels; maximum plasma viremia levels cor-
related with the degree of plasma leakage and thrombocy-
topenia [45]. However, in a previous study from our
group we failed to observe association of IFN-γ with dis-
ease severity [44], probably due to the small number of
severe patients analyzed or to the Dengue-1 incidence.
IFN-γ is produced during a T-lymphocyte helper response
type 1 and may reflect CD8+ T cell activation with produc-
tion of inflammatory cytokines. High levels of IFN-γ were
observed in patients with dengue from Asian and Latin
America and were associated with severity [9]. IFN-γ pro-
duced by T cells may also activate mononuclear phago-
cytes (monocytes and dendritic cells), which would
produce factors such as TNF-α, tissue factor, and platelet-
activating factor, among other mediators. These factors
may all participate in platelet and endothelial cell activa-
tion, leading to platelet consumption, increase in
endothelial permeability, hypotension and ultimately to
shock. IFN-γ has also been associated with secondary het-
erologous Dengue virus infections [47,48] inducing a
strong antigenically cross-reactive inflammatory response,
probably inefficient in terms of antibody and T-cell spe-
cific response. Indeed, we observed earlier in several
patients a CD8+T cell activation with HLA-DR+ subset
increase that was associated with severity [9].
GM-CSF acts at early differentiation processes at myeloid
progenitors or resting monocytes [49]. An additional
stimulus may be required to activate monocytes or den-
dritic cells in order to produce proinflammatory cytokines
[50]. GM-CSF was associated with hypotension as well as
MCP-1, likely acting both in concert, contrasting with
MIP-1β, once more associated with good prognostics.
MCP-1 was earlier detected in DHF patients [51] but for
the first time we reported clinical and laboratory findings
associated with severity.
IL-8 and MCP-1, here associated with thrombocytopenia,
are chemokines and may contribute to platelet activation,
either by their chemoattractant properties or by their
effect on endothelial permeability. Both factors were
detected in patients with DHF [51,52]. These cytokines are
produced by monocytes after various activation stimuli,
such as virus infection, and increase the endothelial per-
meability by disrupting tight junctions among cells [53].
Despite the fact that our study could identify cytokines
with good accuracy for the stratification and/or prognosis
of dengue, it has potential limitations. Here we identified
cytokines related to dengue severity, but the small sample
size represents a shortcoming regarding the generalization
of our results. In addition, only one time point was used
for the measurement of cytokines, not allowing further
insights provided by sequential measurements. Moreover,
classification of disease severity has been a matter of
debate, especially for adult patients' management and
classification. Indeed, the WHO criteria for DHF has failed
to identify severe disease, including fatal cases, in adult
Latin America population [24,54] (S.M.O. Zagne, R.M.O.
Nogueira, unpublished) and clearly do not satisfy the
stratification of our studied population. Accordingly, in
the present study severe disease forms were classified fol-
lowing other proposed criteria [24]. While a direct corre-
lation of cytokine concentrations and the
pathophysiology of severe dengue is tempting, we believe
that the full burden of disease severity cannot be attrib-
uted to a single cytokine. Cytokines may be increased sim-
ply as one of the several steps in the network loops
without necessarily playing a direct harmful role and most
likely more than one factor may be involved, including
others not tested here such as IL-18, TGF-β, and MIF
among others [9].
We can suggest a mechanism explaining our cytokine
models for dengue fever (Figure 3). MIP-1β would be
associated with a protective pathway for its chemoattrac-
tive and activating effect on NK cells, which in turn are
efficient cells in early virus clearance, by their antiviral
cytokine production and cytotoxic activity against
infected target cells. IFN-γ has a deleterious effect for the
host regarding its action in activating T cells for virus anti-BMC Infectious Diseases 2008, 8:86 http://www.biomedcentral.com/1471-2334/8/86
Page 9 of 11
(page number not for citation purposes)
genic cross-reactive response and monocyte/dendritic cell
activation. Mononuclear monocytes are activated by IFN-
γ and GM-CSF among other cytokines and in turn produce
several factors such as IL-1β and MCP-1 that may act on
vascular permeability leading to plasma leakage and
haemoconcentration. As suggested by other authors, it is
likely that viral replication in antigen presenting cells,
cytokine liberation and circulation, and T cell activation
may not be a linear process [55], but in fact a complex
interaction network, with positive and negative feedbacks,
where viral clearance and pathologic events take place,
such as increased vascular permeability and circulatory
collapse, and their balance may determine the disease
outcome.
Conclusion
Our study demonstrated the plasma cytokine profile in
dengue fever from a Brazilian population detected by a
multiplex bead immunoassay. MIP-β is indicated for the
first time as a good prognostic marker and in contrast to
IFN-γ that was associated with the disease severity. Both
cytokines can discriminate mild from severe cases. More-
over, we show here for the first time that during the den-
gue course different cytokine profiles may be present and
vary according to determined clinical manifestations. The
cytokine profiles identified herein by bead array multiplex
system may favour an early identification of patients with
the worst prognosis and may contribute to the establish-
ment of more directed therapeutic procedures than the
present ones.
Hypothetic mechanism to explain cytokine models during dengue fever Figure 3
Hypothetic mechanism to explain cytokine models during dengue fever. MIP-1β is associated with a good prognos-
tic and IFN-γ has a predictive value for severity. GM-CSF, MCP-1, IL-1β, IL-6, IL-8, IL-12, IL-13 are also playing important roles 
during dengue pathogenesis (see text for detailed description).
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